Literature DB >> 23813937

The role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

Pedro J Real, Oscar Navarro-Montero, Verónica Ramos-Mejía, Verónica Ayllón, Clara Bueno, Pablo Menéndez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23813937     DOI： 10.1182/blood-2013-03-487587

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Authors:  C Bueno; J L Sardina; B Di Stefano; D Romero-Moya; A Muñoz-López; L Ariza; M C Chillón; A Balanzategui; J Castaño; A Herreros; M F Fraga; A Fernández; I Granada; O Quintana-Bustamante; J C Segovia; K Nishimura; M Ohtaka; M Nakanishi; T Graf; P Menendez
Journal:  Leukemia       Date:  2015-10-26       Impact factor: 11.528

2.  Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

Authors:  Dan Ran; Kentson Lam; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

3.  Pluripotent Stem Cell-Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial-Mesenchymal Transition-Associated miRNAs.

Authors:  Ellie Meader; Tomas Barta; Dario Melguizo-Sanchis; Katarzyna Tilgner; David Montaner; Ashraf A El-Harouni; Lyle Armstrong; Majlinda Lako
Journal:  Stem Cells       Date:  2017-10-27       Impact factor: 6.277

4.  RUNX1-205, a novel splice variant of the human RUNX1 gene, has blockage effect on mesoderm-hemogenesis transition and promotion effect during the late stage of hematopoiesis.

Authors:  Wencui Sun; Jiahui Zeng; Jing Chang; Yuan Xue; Yonggang Zhang; Xu Pan; Ya Zhou; Mowen Lai; Guohui Bian; Qiongxiu Zhou; Jiaxing Liu; Bo Chen; Feng Ma
Journal:  J Mol Cell Biol       Date:  2020-06-11       Impact factor: 6.216

5.  A Benchmark Side-by-Side Comparison of Two Well-Established Protocols for in vitro Hematopoietic Differentiation From Human Pluripotent Stem Cells.

Authors:  Francisco Gutierrez-Agüera; Virginia Rodriguez-Cortez; Paolo Petazzi; Clara Bueno; Pablo Menendez
Journal:  Front Cell Dev Biol       Date:  2021-05-21

Review 6.  Concise review: programming human pluripotent stem cells into blood.

Authors:  Jennifer Easterbrook; Antonella Fidanza; Lesley M Forrester
Journal:  Br J Haematol       Date:  2016-03-21       Impact factor: 6.998

7.  A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.

Authors:  Yulin Xu; Wei Shan; Xia Li; Binsheng Wang; Senquan Liu; Yebo Wang; Yan Long; Ruxiu Tie; Limengmeng Wang; Shuyang Cai; Hao Zhang; Yu Lin; Mingming Zhang; Weiyan Zheng; Yi Luo; Xiaohong Yu; Jiing-Kuan Yee; Junfeng Ji; He Huang
Journal:  J Hematol Oncol       Date:  2016-09-29       Impact factor: 17.388

8.  RUNX1: an emerging therapeutic target for cardiovascular disease.

Authors:  Alexandra Riddell; Martin McBride; Thomas Braun; Stuart A Nicklin; Ewan Cameron; Christopher M Loughrey; Tamara P Martin
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.